142 related articles for article (PubMed ID: 1600590)
1. Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations.
Kötting J; Berger MR; Unger C; Eibl H
Cancer Chemother Pharmacol; 1992; 30(2):105-12. PubMed ID: 1600590
[TBL] [Abstract][Full Text] [Related]
2. Hexadecylphosphocholine differs from conventional cytostatic agents.
Berger MR; Betsch B; Gebelein M; Amtmann E; Heyl P; Scherf HR
J Cancer Res Clin Oncol; 1993; 119(9):541-8. PubMed ID: 8392075
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carcinomas.
Berger MR; Yanapirut P; Reinhardt M; Klenner T; Scherf HR; Schmeiser HH; Eibl H
Prog Exp Tumor Res; 1992; 34():98-115. PubMed ID: 1438807
[No Abstract] [Full Text] [Related]
4. Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.
Kaufmann-Kolle P; Berger MR; Unger C; Eibl H
Adv Exp Med Biol; 1996; 416():165-8. PubMed ID: 9131143
[No Abstract] [Full Text] [Related]
5. Antineoplastic activity in vitro of free and liposomal alkylphosphocholines.
Zeisig R; Jungmann S; Arndt D; Schütt A; Nissen E
Anticancer Drugs; 1993 Feb; 4(1):57-64. PubMed ID: 8457716
[TBL] [Abstract][Full Text] [Related]
6. Alkyl phosphocholines: toxicity and anticancer properties.
Muschiol C; Berger MR; Schuler B; Scherf HR; Garzon FT; Zeller WJ; Unger C; Eibl HJ; Schmähl D
Lipids; 1987 Nov; 22(11):930-4. PubMed ID: 3444388
[TBL] [Abstract][Full Text] [Related]
7. In vitro investigations on the antineoplastic effect of hexadecylphosphocholine.
Yanapirut P; Berger MR; Reinhardt M; Schmähl D
Arzneimittelforschung; 1991 Jun; 41(6):652-5. PubMed ID: 1930356
[TBL] [Abstract][Full Text] [Related]
8. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
Sobottka SB; Berger MR
Cancer Chemother Pharmacol; 1992; 30(5):385-93. PubMed ID: 1505077
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.
Kaufmann-Kolle P; Drevs J; Berger MR; Kötting J; Marschner N; Unger C; Eibl H
Cancer Chemother Pharmacol; 1994; 34(5):393-8. PubMed ID: 8070005
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of alkylphosphocholines in different murine tumor models: use of liposomal preparations.
Zeisig R; Fichtner I; Arndt D; Jungmann S
Anticancer Drugs; 1991 Aug; 2(4):411-7. PubMed ID: 1797199
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomes.
Fichtner I; Zeisig R; Naundorf H; Jungmann S; Arndt D; Asongwe G; Double JA; Bibby MC
Breast Cancer Res Treat; 1994; 32(3):269-79. PubMed ID: 7865855
[TBL] [Abstract][Full Text] [Related]
12. Hexadecylphosphocholine: a new and selective antitumor drug.
Eibl H; Unger C
Cancer Treat Rev; 1990 Sep; 17(2-3):233-42. PubMed ID: 2272038
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506).
Hilgard P; Stekar J; Voegeli R; Engel J; Schumacher W; Eibl H; Unger C; Berger MR
Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1457-61. PubMed ID: 3141197
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of four anti-cancer alkylphosphocholine derivatives in vitro and in vivo.
Sobottka SB; Berger MR; Eibl H
Int J Cancer; 1993 Feb; 53(3):418-25. PubMed ID: 8428795
[TBL] [Abstract][Full Text] [Related]
15. The effects of hexadecylphosphocholine (HPC) a mixture of alkylphosphocholines (APC) and different dietary oils on the growth of a human mammary tumor.
Colombo DT; Tran LK; Reitz RC
Proc West Pharmacol Soc; 1993; 36():127-31. PubMed ID: 8378365
[No Abstract] [Full Text] [Related]
16. Influence of the alkyllysophospholipid ET-18-OCH3 on methylnitrosourea-induced rat mammary carcinomas.
Berger MR; Munder PG; Schmähl D; Westphal O
Oncology; 1984; 41(2):109-13. PubMed ID: 6538675
[TBL] [Abstract][Full Text] [Related]
17. DNA methyl-adduct dosimetry and O6-alkylguanine-DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N-methylnitrosourea.
Fong LY; Jensen DE; Magee PN
Carcinogenesis; 1990 Mar; 11(3):411-7. PubMed ID: 2311184
[TBL] [Abstract][Full Text] [Related]
18. Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment.
Marschner N; Kötting J; Eibl H; Unger C
Cancer Chemother Pharmacol; 1992; 31(1):18-22. PubMed ID: 1458555
[TBL] [Abstract][Full Text] [Related]
19. Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats.
Reinhardt M; Heyl P; Amelung F; Berger MR
Arzneimittelforschung; 1992 Oct; 42(10):1239-42. PubMed ID: 1282010
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic activity of ET-18-OCH3 and hexadecylphosphocholine against mammary tumors in BD-VI rats.
Scherf HR; Schuler B; Berger MR; Schmähl D
Lipids; 1987 Nov; 22(11):927-9. PubMed ID: 3444387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
